Enapotamab vedotin Antibody

SKU: orb2302552

Description

Enapotamab vedotin is an investigational AXL-targeting antibody-drug conjugate (ADC) delivering MMAE to disrupt microtubules. It shows potent activity in preclinical models of high-AXL NSCLC, including EGFR inhibitor-resistant tumors, supporting its study in both in vitro and in vivo oncology research.

Research Area

Signal Transduction

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Monoclonal
Target	TAM Receptor,Antibody-Drug Conjugates (ADCs)
Molecular Weight	150.63 kDa
Purity	>95.0% (May vary between batches)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Concentration	7.49 mg/mL
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

HuMAX-AXL-ADC, EnaV, EnaV, HuMAX-AXL-ADC

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

TAM Receptor,Antibody-Drug Conjugates (ADCs)

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols